LBA24 Neoadjuvant immunotherapy in locally advanced MMR-deficient colon cancer: 3-year disease-free survival from NICHE-2
Myriam Chalabi, L.D.W. van den Dungen, Y.L. Verschoor, Sara Balduzzi, P.G.M. de Gooyer, Niels F.M. Kok, E. Kerver, Cecile Grootscholten, Emile E. Voest, Jacobus W. A. Burger, Eduard R. Hendriks, Thomas R. de Wijkerslooth, T. Tin, T.S. Aukema, Steven J. Oosterling, Arend G. J. Aalbers, José G. van den Berg, Monique E. van Leerdam, Ton N. Schumacher, J.B.A.G. Haanen
Topics & Concepts
MedicineColorectal cancerImmunotherapyNicheOncologyInternal medicineNeoadjuvant therapyCancerBiologyBreast cancerEcologyColorectal and Anal CarcinomasCancer Immunotherapy and BiomarkersGenetic factors in colorectal cancer